Ekta Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 03-01-2025
- Paid Up Capital ₹ 1.75 M
as on 03-01-2025
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 03-01-2025
- Revenue %
(FY 2020)
- Profit -146.55%
(FY 2020)
- Ebitda -1062.50%
(FY 2020)
- Net Worth -0.89%
(FY 2020)
- Total Assets %
(FY 2020)
About Ekta Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 1.75 M.
The company currently has active open charges totaling ₹2.50 M.
Suresh Jerath and Sudhir Sethi serve as directors at the Company.
- CIN/LLPIN
U15331DL1998PTC094153
- Company No.
094153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ekta Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Jerath  | Director | 28-May-1998 | Current |
| Sudhir Sethi | Director | 28-May-1998 | Current |
Financial Performance of Ekta Biotech.
Ekta Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 146.55% decrease in profit. The company's net worth dipped by a decrease of 0.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ekta Biotech?
Unlock access to Ekta Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ekta Agro Industries LimitedActive 37 years 8 monthsSuresh Jerath and Sudhir Sethi are mutual person
- Shradha Fincap Private LimitedActive 28 years 10 months
Suresh Jerath and Sudhir Sethi are mutual person
- Ekta Finport Services Private LimitedActive 28 years 3 months
Suresh Jerath and Sudhir Sethi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2017 | ₹2.50 M | Open |
How Many Employees Work at Ekta Biotech?
Unlock and access historical data on people associated with Ekta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ekta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
